Table 3.
Study | Disease | Sample types | Platform | Thresholds for identification pathogen by mNGS |
---|---|---|---|---|
Zhang Y. et al. [81] | Pneumocystis pneumonia | Sputum, blood, lung tissue and BALF | NA |
|
Wang J. et al. [7] | Mixed pulmonary infection | BALF and lung tissue | NA | The infectious pathogen was determined if it met any of the following thresholds: |
| ||||
| ||||
| ||||
Li H. et al.[5] | Pulmonary infection | Lung tissues | BGISEQ-500 | The infectious pathogens were determined if it met any of the following thresholds: |
| ||||
| ||||
| ||||
Huang J. et al. [54] | Peripheral pulmonary infection | Lung tissue, BALF, and protected-specimen brush. | BGISEQ-100 | The criteria for a positive mNGS test result included: |
| ||||
| ||||
| ||||
| ||||
Langelier C. et al. [17] | LRTIs | BALF | illumina | Microbes identified were classified as confirmed pathogens if |
| ||||
| ||||
| ||||
| ||||
| ||||
Charalampous, T. et al. [3] | Bacterial lower respiratory infection | Sputum, BALF and ETAs | MinION |
|
Wang, H. et al. [55] | Severe nonresponding pneumonia | BALF | BGISEQ-100 |
|
| ||||
| ||||
| ||||
|
Abbreviations: BALF, broncho-alveolar lavage fluid; ETA, endotracheal tube aspirate; IPA, invasive pulmonary aspergillosis; MTBC, Mycobacterium tuberculosis complex; MTC, Mycobacterium tuberculosis complex; NA, no accessible; SDSMRN, the number of reads stringently mapped to pathogen species; SMRN, stringent map read number; WIMP, ‘What’s In My Pot?’ pipeline.